CN108606222A - 一种祛糖尿病肽复配的固体饮料及其制备方法 - Google Patents
一种祛糖尿病肽复配的固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN108606222A CN108606222A CN201810576784.0A CN201810576784A CN108606222A CN 108606222 A CN108606222 A CN 108606222A CN 201810576784 A CN201810576784 A CN 201810576784A CN 108606222 A CN108606222 A CN 108606222A
- Authority
- CN
- China
- Prior art keywords
- lys
- gly
- peptide
- polysaccharide
- mushroom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 36
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 25
- 239000007787 solid Substances 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims abstract description 15
- 238000013329 compounding Methods 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 36
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims abstract description 36
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 17
- 239000005017 polysaccharide Substances 0.000 claims abstract description 17
- 150000004676 glycans Chemical class 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 10
- 240000006794 Volvariella volvacea Species 0.000 claims abstract description 9
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 229920002678 cellulose Polymers 0.000 claims abstract description 8
- 239000001913 cellulose Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 241000414067 Inonotus obliquus Species 0.000 claims abstract description 5
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 5
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 5
- 241001486992 Taiwanofungus camphoratus Species 0.000 claims abstract description 5
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims abstract description 4
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims abstract description 4
- 244000298697 Actinidia deliciosa Species 0.000 claims abstract description 4
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 4
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 4
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 4
- 241001070941 Castanea Species 0.000 claims abstract description 4
- 235000014036 Castanea Nutrition 0.000 claims abstract description 4
- 229920002101 Chitin Polymers 0.000 claims abstract description 4
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 4
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 4
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 4
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 4
- 241001251068 Formica fusca Species 0.000 claims abstract description 4
- 102000002068 Glycopeptides Human genes 0.000 claims abstract description 4
- 108010015899 Glycopeptides Proteins 0.000 claims abstract description 4
- 241001534110 Lactarius <percoid fish> Species 0.000 claims abstract description 4
- 229920001543 Laminarin Polymers 0.000 claims abstract description 4
- 239000005717 Laminarin Substances 0.000 claims abstract description 4
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 4
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 4
- 241000124033 Salix Species 0.000 claims abstract description 4
- 241000272503 Sparassis radicata Species 0.000 claims abstract description 4
- 241000222562 Suillus Species 0.000 claims abstract description 4
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 4
- 235000008434 ginseng Nutrition 0.000 claims abstract description 4
- 239000004615 ingredient Substances 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 235000013305 food Nutrition 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims description 2
- 230000001151 other effect Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 239000013585 weight reducing agent Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 206010018473 Glycosuria Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 101100042648 Drosophila melanogaster sing gene Proteins 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- -1 amino acid polysaccharide unsaturated fatty acid Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 101100332641 Caenorhabditis elegans eat-4 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GXBPITKCTXKSEI-UHFFFAOYSA-N [Cr].[Mg].[Zn] Chemical compound [Cr].[Mg].[Zn] GXBPITKCTXKSEI-UHFFFAOYSA-N 0.000 description 1
- MLYSYIWLARMYPO-UHFFFAOYSA-N [P].[Ca].[Fe] Chemical group [P].[Ca].[Fe] MLYSYIWLARMYPO-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001904 diabetogenic effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种祛糖尿病肽复配的固体饮料及其制备方法，以白桦茸肽粉，牛樟芝肽粉，绣球菌糖肽，鹰嘴豆肽粉，松茸肽粉，红菇肽粉，松乳菇肽粉，荞麦肽粉，草菇肽粉，栗蘑肽粉，西洋参肽，白牛肝菌肽粉，辣木籽肽粉，黑蚂蚁肽粉，铁皮石斛多糖，青钱柳叶多糖等为主料，以蘑菇纤维素，草菇纤维素，海带多糖，马齿苋多糖，蜂花粉，灵芝孢子粉，人参花粉，甲壳素，猕猴桃粉，冬瓜粉等为辅料，经过称重、混合、制粒、干燥、杀菌、包装等工艺复合而制成肽固体饮料，具有调理血糖，提高免疫力，排毒抗氧化，清除自由基的功效。
Description
技术领域
本发明涉及一种祛糖尿病肽复配的固体饮料及其制备方法，属于固体颗粒加工技术领域。是一种高级新资源食品。
背景技术
本发明提供了一种祛糖尿病肽复配的固体饮料及其制备方法。胰岛素抵抗和绝对缺乏，胰岛变异不能合成胰岛素等都是二型糖尿病产生的原因。白桦茸，草菇等食物都有治疗糖尿病的功效，用这些食物提取的小分子活性肽，能主动全部被小肠吸收进入血液，修复导致糖尿病的损坏细胞，生成祛除糖尿病的新细胞，满足人体各系统对营养所需，提高免疫力，用若干种具有相同功效的小分子肽复配制成肽固体饮料，效果更好，是高营养食品。此外，一些植物多糖可预防糖尿病，食用4一7个小时侯血糖降糖率56.45％。双向调节，提高对胰岛素的敏感性，保护胰腺功能。海带、苦瓜、薏仁、木耳、香菇、马齿苋、银耳等多糖防治糖尿病都有一定作为。与具有降糖作用的小分子肽复配，还可以提高人体对这些大分子多糖消化吸收利用率并快速发生功效。
本发明将会为具有科学营养配比的肽固体颗粒领域提供发展方向。
发明内容
本发明的目的是提供一种祛糖尿病肽复配的固体饮料及其制备方法。所得固体颗粒口味佳，便于冲饮，本发明工艺设计科学合理，操作简便易行。
本发明的技术方案：一种祛糖尿病肽复配的固体饮料及其制备方法。取靶向作用的以下原料：1、白桦茸肽，调理肠胃治疗肝脏疾病，预防感冒对流行病毒抑制，抗衰老抗癌降血压(精粉83％)降血糖(93％)并发症，所含多糖水溶性纤维是降糖的主要力量，抗病毒降胰岛毒性促进胰岛素分泌。(小分子肽，多糖，精粉)2、牛樟芝肽，解百毒保肝肾治疗糖尿病。3、绣球菌糖肽，超氧化物岐化酶(SOD)在食用菌中最高，抗氧化，有效清除自由基防损伤肌体抗衰老。阝_葡聚糖高达43.6g，是灵芝姬松茸的4倍，免疫调节抗肿瘤(抑制率99％)，抗炎抗病毒抗氧化抗辐射降血糖降血脂保肝，高血压心脑血等疾病，骨质疏松软化，提高免疫力，抗癌防癌效果显著。(医疗保健作用)。4、鹰嘴豆肽，治疗糖尿病心血管病补血补钙、高血压血脂，含铬，控制减少血糖防并发症。铬：调节血糖三大因胰岛素(活性降低)，葡萄糖耐量受体(受损)和胰岛受体(数量减少)。5、松茸肽，治疗糖尿病，刺激胰岛分泌胰岛素，保护和修复胰岛细胞，增加体内胰岛素含量，改善胰岛素抵抗，加速肝葡萄糖代谢。6、红菇肽，主治糖尿病，7、松乳菇肽粉，治疗糖尿病及症效果好。8、荞麦肽，含铬增加胰蛋素活性防治糖尿病。9、草菇肽，VC高提高免疫力抗病力强身健体造血铁钙磷骨胳元素，儿童生长老年骨质疏松。不饱和脂肪酸粗纤维降低血糖浓度。10、栗蘑肽，含硒铬锌治糖尿病。11、西洋参肽，治疗糖尿病。12、白牛肝菌肽，抗癌排毒治疗糖尿病。13、辣木籽肽，清人体各系统毒素。降三高。14、黑蚂蚁肽，改善糖尿病，从根本上解决胰岛素异常，对终身服药的解放，填精益髓补肾强壮滋补肝肾益气养血活血化瘀。丰富的氨基酸多糖不饱和脂肪酸，修复胰岛细胞所需的大量的锌镁铬等，从根本上恢复胰岛细胞的功能。15、铁皮石斛多糖，治疗糖尿病{肾阴虚肺胃早热气阴两虚为病基特征，能滋阴清热润燥增胰蛋活性降血病水恢复正常(专用药)。16、青钱柳叶多糖，降三高降血糖减肥防冶心脑血管病。17、牛樟芝肽，防癌抗癌。以上为主料。另取辅料：1、蘑菇纤维素，治疗糖尿病。2、草菇纤维素，治疗糖尿病。3、海带多糖，适应血糖高并高脂血症降低血清胆固醇和甘油酸脂。4、马齿苋多糖，减轻糖尿病患者″三多一少″症状。5、蜂花粉，保肝解毒益肾治糖尿病。6、灵芝孢子粉，降血糖保肝解毒增加胰岛分泌胰岛素的的功能降低血糖浓度。7、人参花粉，解渴解毒提神降压降脂降血糖心血管疾病脑血栓老年疾呆调阴阳平衡强免疫力抗癌万年养生品(不能多用)抗癌。8、甲壳素，当代病慢性病克星。9、猕猴桃粉，营养全面促进新陈代谢。10、冬瓜粉，降低血糖水平排肠道致癌物防治三高增人体免疫力护肾利尿。这些为辅料。这些主辅料经过称重量，混合，干燥，制丸，包装得到肽固体饮料。
本发明的有效果：采用本发明生产的固体饮料，在常温中即可溶解，具有调理糖尿病的功效，还具有提高免疫力，抗病力的作用。
具体实施方式
一种祛糖尿病肽复配的固体饮料及其制备方法的具体实施方式为：
1、取白桦茸肽粉15％，牛樟芝肽粉10％，绣球菌糖肽6％，鹰嘴豆肽粉6％，松茸肽粉6％，红菇肽粉6％，松乳菇肽粉6％，荞麦肽粉5％，草菇肽粉5％，栗蘑肽粉5％，西洋参肽5％，白牛肝菌肽粉5％，辣木籽肽粉5％，黑蚂蚁肽粉5％，铁皮石斛多糖5％，青钱柳叶多糖5％等这些主料，按各自占比称重量，混合均匀。
2、取辅料：蘑菇纤维素，草菇纤维素，海带多糖，马齿苋多糖，蜂花粉，灵芝孢子粉，人参花粉，甲壳素，猕猴桃粉，冬瓜粉等各4％，混合均匀。
3、将主辅料用混合机混合均匀。
4、用制丸机制成固体颗粒。
5、干燥杀菌。
6、用包装机包装成袋。
7、封装入库。
本发明的肽固体饮料，还有增强体质，减肥胖等功效，是健康中国的理想食品。
Claims (2)
1.本发明的一种祛糖尿病肽复配的固体饮料及其制备方法的技术特征为：
(1)取白桦茸肽粉15％，牛樟芝肽粉10％，绣球菌糖肽6％，鹰嘴豆肽粉6％，松茸肽粉6％，红菇肽粉6％，松乳菇肽粉6％，荞麦肽粉5％，草菇肽粉5％，栗蘑肽粉5％，西洋参肽5％，白牛肝菌肽粉5％，辣木籽肽粉5％，黑蚂蚁肽粉5％，铁皮石斛多糖5％，青钱柳叶多糖5％等这些主料，按各自占比称重量混合均匀。
(2)取辅料：蘑菇纤维素，草菇纤维素，海带多糖，马齿苋多糖，蜂花粉，灵芝孢子粉，人参花粉，甲壳素，猕猴桃粉，冬瓜粉等各4％，混合均匀。
(3)将主辅料用混合机混合均匀。
(4)用制丸机制成固体颗粒。
(5)干燥杀菌。
(6)用包装机包装成袋。
(7)封装入库。
2.本发明的肽固体饮料，还有增强体质，减肥胖等功效，是健康中国的理想食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810576784.0A CN108606222A (zh) | 2018-06-06 | 2018-06-06 | 一种祛糖尿病肽复配的固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810576784.0A CN108606222A (zh) | 2018-06-06 | 2018-06-06 | 一种祛糖尿病肽复配的固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108606222A true CN108606222A (zh) | 2018-10-02 |
Family
ID=63664814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810576784.0A Pending CN108606222A (zh) | 2018-06-06 | 2018-06-06 | 一种祛糖尿病肽复配的固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108606222A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109549217A (zh) * | 2019-01-09 | 2019-04-02 | 丁强 | 一种以白桦茸多肽、舞茸多肽等多种成分复配制备的特膳食品 |
| CN114403456A (zh) * | 2022-01-27 | 2022-04-29 | 华南理工大学 | 一种具有特效降血糖和改善糖尿病并发症作用的草本全谷物方便主食及其工业化生产方法 |
| CN116509777A (zh) * | 2023-02-14 | 2023-08-01 | 太和康美(北京)中医研究院有限公司 | 保湿组合物及其制备方法和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440448B1 (en) * | 1998-03-16 | 2002-08-27 | Joseph Intelisano | Food supplement/herbal composition for health enhancement |
| CN107432397A (zh) * | 2017-09-29 | 2017-12-05 | 唐山十三肽保生物工程技术有限公司 | 一种人参小分子肽复配的固体饮料及其制备方法 |
| CN107616401A (zh) * | 2017-09-29 | 2018-01-23 | 唐山十三肽保生物工程技术有限公司 | 一种猴头菇小分子肽复配的固体饮料及其制备方法 |
| CN107668459A (zh) * | 2017-10-13 | 2018-02-09 | 唐山十三肽保生物工程技术有限公司 | 一种香菇小分子肽复配的固体饮料及其制备方法 |
| CN107739683A (zh) * | 2017-10-13 | 2018-02-27 | 唐山十三肽保生物工程技术有限公司 | 一种花菇小分子肽复配酒及其制备方法 |
-
2018
- 2018-06-06 CN CN201810576784.0A patent/CN108606222A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440448B1 (en) * | 1998-03-16 | 2002-08-27 | Joseph Intelisano | Food supplement/herbal composition for health enhancement |
| CN107432397A (zh) * | 2017-09-29 | 2017-12-05 | 唐山十三肽保生物工程技术有限公司 | 一种人参小分子肽复配的固体饮料及其制备方法 |
| CN107616401A (zh) * | 2017-09-29 | 2018-01-23 | 唐山十三肽保生物工程技术有限公司 | 一种猴头菇小分子肽复配的固体饮料及其制备方法 |
| CN107668459A (zh) * | 2017-10-13 | 2018-02-09 | 唐山十三肽保生物工程技术有限公司 | 一种香菇小分子肽复配的固体饮料及其制备方法 |
| CN107739683A (zh) * | 2017-10-13 | 2018-02-27 | 唐山十三肽保生物工程技术有限公司 | 一种花菇小分子肽复配酒及其制备方法 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109549217A (zh) * | 2019-01-09 | 2019-04-02 | 丁强 | 一种以白桦茸多肽、舞茸多肽等多种成分复配制备的特膳食品 |
| CN114403456A (zh) * | 2022-01-27 | 2022-04-29 | 华南理工大学 | 一种具有特效降血糖和改善糖尿病并发症作用的草本全谷物方便主食及其工业化生产方法 |
| CN116509777A (zh) * | 2023-02-14 | 2023-08-01 | 太和康美(北京)中医研究院有限公司 | 保湿组合物及其制备方法和应用 |
| CN116509777B (zh) * | 2023-02-14 | 2024-01-12 | 太和康美(北京)中医研究院有限公司 | 保湿组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991112A (zh) | 一种能够稳定餐后血糖功能的保健食品 | |
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| CN110771825A (zh) | 一种用于减脂、降血糖、降血压和降血脂的综合营养粉及其制备方法 | |
| CN108606222A (zh) | 一种祛糖尿病肽复配的固体饮料及其制备方法 | |
| CN104605353A (zh) | 适用于手术后肿瘤患者食用的配方食品及其制备方法 | |
| CN102178183A (zh) | 一种五豆综合营养食品 | |
| CN110367526A (zh) | 一种低糖高纤维营养代餐粉 | |
| CN106616280A (zh) | 一种补肾护肝提高免疫力的保健营养粉及其制备方法 | |
| CN107897908A (zh) | 一种适用于减肥瘦身的早餐冲调食疗组合物及其制备方法 | |
| CN111671020A (zh) | 一种黄精饮料及其制备方法 | |
| CN108308597A (zh) | 一种营养不良专用型临床营养配方及其制备方法 | |
| CN110547461A (zh) | 一种沙棘白刺藜麦代餐粉及其制备方法 | |
| CN102742767A (zh) | 一种苦荞蔬菜营养保健饭及其生产工艺 | |
| CN109170888A (zh) | 一种抗氧化、抗疲劳组合物及其制备方法 | |
| CN108782679A (zh) | 一种减肥干预代餐饼干及其制备方法 | |
| CN111771970A (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
| CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
| CN109497470A (zh) | 一种蛋白核小球藻多肽缓解增肥组合物及其制备方法 | |
| CN108260802A (zh) | 一种老年患者专用型临床营养配方及其制备方法 | |
| CN105475855B (zh) | 高纤维绿豆蛋白肽复合营养食品及其绿色生产方法 | |
| CN112998115A (zh) | 一种排油减肥的压片果糖及其制备方法 | |
| CN113841884A (zh) | 改善营养代谢的速溶代餐粉配方及其制作方法 | |
| CN113842452A (zh) | 治疗糖尿病的药物组合物及其制备方法 | |
| CN113812637A (zh) | 术前术后营养补充剂及应用 | |
| CN107836707B (zh) | 一种具有改善糖脂代谢紊乱的健康食品基料的制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181002 |
|
| WD01 | Invention patent application deemed withdrawn after publication |